Profil
Charlotte Dyring is the founder.
Founded ExpreS2ion Biotechnologies ApS in 2009 as Chief Operating Officer.
Founded Expres2ion Biotech Holding AB in 2010 as Chief Operating Officer.
Founded Kripthonite Therapeutics ApS in 2023 as Chief Operating Officer.
Former job at Pharmexa A as Principal.
Former job at Kabi Pharmacia as Principal.
Education includes a doctorate from Technical University of Denmark conferred in 1992 and an undergraduate degree from The Danish Academy of Technical Sciences.
Aktive Positionen von Charlotte Dyring
| Unternehmen | Position | Beginn |
|---|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Gründer | 01.01.2009 |
Ehemalige bekannte Positionen von Charlotte Dyring
| Unternehmen | Position | Ende |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Gründer | 01.12.2020 |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
Kabi Pharmacia | Corporate Officer/Principal | - |
Ausbildung von Charlotte Dyring
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Danish Academy of Technical Sciences
The Danish Academy of Technical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kabi Pharmacia | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
















